Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.3252

-0.0048 (-1.45%)

At close: May 13, 2025, 4:00 PM

0.3250

-0.0002 (-0.06%)

Pre-market: May 14, 2025, 7:02 AM EDT

Aspire Biopharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.02	0.01	0
Cash & Short-Term Investments	0.02	0.01	0
Cash Growth	43428.95%	29305.26%	-
Prepaid Expenses	0.17	0.04	0.02
Total Current Assets	0.18	0.05	0.02
Total Assets	0.18	0.05	0.02
Accounts Payable	0.13	0.17	0.12
Short-Term Debt	0.85	0.36	0.03
Other Current Liabilities	0	0	0
Total Current Liabilities	0.99	0.53	0.15
Other Long-Term Liabilities	-	-	0
Total Liabilities	0.99	0.53	0.15
Common Stock	0.22	0.22	0.22
Additional Paid-In Capital	1.02	0.76	0.76
Retained Earnings	-2.04	-1.47	-1.11
Shareholders' Equity	-0.8	-0.49	-0.13
Total Liabilities & Equity	0.18	0.05	0.02
Total Debt	0.85	0.36	0.03
Net Cash (Debt)	-0.84	-0.35	-0.03
Net Cash Per Share	-0.00	-0.00	-
Filing Date Shares Outstanding	443.32	443	-
Total Common Shares Outstanding	443.32	443	-
Working Capital	-0.8	-0.49	-0.13
Book Value Per Share	-0.00	-0.00	-
Tangible Book Value	-0.8	-0.49	-0.13
Tangible Book Value Per Share	-0.00	-0.00	-

Updated Jan 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.